Literature DB >> 29389213

Tobacco withdrawal among opioid-dependent smokers.

Joanna M Streck1, Sarah H Heil2, Stephen T Higgins2, Janice Y Bunn3, Stacey C Sigmon4.   

Abstract

Prevalence of cigarette smoking among opioid-dependent individuals is 6-fold that of the general U.S. adult population and their quit rates are notoriously poor. One possible reason for the modest cessation outcomes in opioid-dependent smokers may be that they experience more severe tobacco withdrawal upon quitting. In this secondary analysis, we evaluated tobacco withdrawal in opioid-dependent (OD) smokers versus smokers without co-occurring substance use disorders (SUDs). Participants were 47 methadone- or buprenorphine-maintained smokers and 25 non-SUD smokers who completed 1 of several 2-week studies involving daily visits for biochemical monitoring, delivery of financial incentives contingent on smoking abstinence, and assessment of withdrawal via the Minnesota Nicotine Withdrawal Scale (MNWS). Prior to quitting smoking, OD smokers presented with higher baseline withdrawal scores than non-SUD smokers (1.7 ± 0.2 vs. 0.7 ± 0.2, respectively; F[1, 63] = 7.31, p < .001). Withdrawal scores in both groups decreased over the subsequent 2-week period with no group differences, F(1, 910) = 0.50, p = .48. A similar pattern was observed on craving (i.e., Desire to Smoke item of MNWS), although the trajectory of decrease over time on this item was also moderated by gender. Overall, there was no difference in withdrawal during biochemically verified smoking abstinence between OD and non-SUD smokers, suggesting that elevated withdrawal severity following quitting may not be a major factor contributing to the poor cessation outcomes consistently observed among OD smokers. Further scientific efforts are needed to improve our understanding of the high smoking rates and modest cessation outcomes in this challenging population. (PsycINFO Database Record (c) 2018 APA, all rights reserved).

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29389213      PMCID: PMC5897167          DOI: 10.1037/pha0000185

Source DB:  PubMed          Journal:  Exp Clin Psychopharmacol        ISSN: 1064-1297            Impact factor:   3.157


  32 in total

1.  Determinants of tobacco use and renaming the FTND to the Fagerstrom Test for Cigarette Dependence.

Authors:  Karl Fagerström
Journal:  Nicotine Tob Res       Date:  2011-10-24       Impact factor: 4.244

Review 2.  Effects of abstinence from tobacco: valid symptoms and time course.

Authors:  John R Hughes
Journal:  Nicotine Tob Res       Date:  2007-03       Impact factor: 4.244

3.  Treating cigarette smoking in methadone maintenance clients.

Authors:  J Story; M J Stark
Journal:  J Psychoactive Drugs       Date:  1991 Apr-Jun

4.  Examining the effects of initial smoking abstinence on response to smoking-related stimuli and response inhibition in a human laboratory model.

Authors:  Matthew P Bradstreet; Stephen T Higgins; F Joseph McClernon; Rachel V Kozink; Joan M Skelly; Yukiko Washio; Alexa A Lopez; Marie A Parry
Journal:  Psychopharmacology (Berl)       Date:  2013-12-15       Impact factor: 4.530

5.  Sex differences in negative affect and lapse behavior during acute tobacco abstinence: a laboratory study.

Authors:  Raina D Pang; Adam M Leventhal
Journal:  Exp Clin Psychopharmacol       Date:  2013-07-08       Impact factor: 3.157

6.  Tobacco use and quit attempts among methadone maintenance clients.

Authors:  K P Richter; C A Gibson; J S Ahluwalia; K H Schmelzle
Journal:  Am J Public Health       Date:  2001-02       Impact factor: 9.308

7.  Current Cigarette Smoking Among Adults - United States, 2005-2015.

Authors:  Ahmed Jamal; Brian A King; Linda J Neff; Jennifer Whitmill; Stephen D Babb; Corinne M Graffunder
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-11-11       Impact factor: 17.586

8.  Smokers' sex and the effects of tobacco cigarettes: subject-rated and physiological measures.

Authors:  T Eissenberg; C Adams; E C Riggins; M Likness
Journal:  Nicotine Tob Res       Date:  1999-12       Impact factor: 4.244

9.  Sex differences in tobacco withdrawal syndrome.

Authors:  D S Svikis; D K Hatsukami; J R Hughes; K M Carroll; R W Pickens
Journal:  Addict Behav       Date:  1986       Impact factor: 3.913

10.  Changes in the relative reinforcing effects of cigarette smoking as a function of initial abstinence.

Authors:  Jin H Yoon; Stephen T Higgins; Matthew P Bradstreet; Gary J Badger; Colleen S Thomas
Journal:  Psychopharmacology (Berl)       Date:  2009-04-24       Impact factor: 4.530

View more
  6 in total

1.  Investigating tobacco withdrawal in response to reduced nicotine cigarettes among smokers with opioid use disorder and other vulnerabilities.

Authors:  Joanna M Streck; Stacey C Sigmon; Jeffrey Priest; Cecilia L Bergeria; Danielle R Davis; John R Hughes; Andrea C Villanti; Jennifer W Tidey; Sarah H Heil; Diann E Gaalema; Maxine L Stitzer; Stephen T Higgins
Journal:  Exp Clin Psychopharmacol       Date:  2020-02-06       Impact factor: 3.157

2.  Associations between opioid and nicotine dependence in nationally representative samples of United States adult daily smokers.

Authors:  Maria A Parker; Joanna M Streck; Stacey C Sigmon
Journal:  Drug Alcohol Depend       Date:  2018-03-15       Impact factor: 4.492

Review 3.  Consensus statement on smoking cessation in patients with pain.

Authors:  Hiroki Iida; Shigeki Yamaguchi; Toru Goyagi; Yoko Sugiyama; Chie Taniguchi; Takako Matsubara; Naoto Yamada; Hiroshi Yonekura; Mami Iida
Journal:  J Anesth       Date:  2022-09-07       Impact factor: 2.931

Review 4.  A review of tobacco regulatory science research on vulnerable populations.

Authors:  Stephen T Higgins; Allison N Kurti; Marissa Palmer; Jennifer W Tidey; Antonio Cepeda-Benito; Maria R Cooper; Nicolle M Krebs; Lourdes Baezconde-Garbanati; Joy L Hart; Cassandra A Stanton
Journal:  Prev Med       Date:  2019-05-02       Impact factor: 4.018

5.  Quit ratios for cigarette smoking among individuals with opioid misuse and opioid use disorder in the United States.

Authors:  Maria A Parker; Andrea H Weinberger; Andrea C Villanti
Journal:  Drug Alcohol Depend       Date:  2020-07-02       Impact factor: 4.492

6.  Implementation and Outcomes of a Comprehensive Tobacco Free Workplace Program in Opioid Treatment Centers.

Authors:  Matthew Taing; Vijay Nitturi; Tzuan A Chen; Bryce Kyburz; Isabel Martinez Leal; Virmarie Correa-Fernández; Ezemenari M Obasi; Teresa Williams; Kathleen Casey; Daniel P O'Connor; Litty Koshy; Maggie Britton; Kelli Drenner; Lorraine R Reitzel
Journal:  Int J Environ Res Public Health       Date:  2021-12-26       Impact factor: 4.614

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.